Adverum Biotechnologies: Relating To The Private Placements Is Hereby Incorporated By Reference Into This Item 3.02. Based In Part Upon The Representations Of The Investors In The Securities Purchase Agreement, The Offering And Sale Of The Securities Will Be Made In Reliance On The Exemption Afforded By Regulation D Under The Securities Act Of 1933, As Amended (the Securities Act ), And Corresponding Provisions Of State Securities Or Blue Sky Laws. The Securities Issued In The Private Placements Will Not Be Registered Under The Securities Act Or Any State Securities Laws And May Not Be Offered Or Sold In The United States Absent Registration With The Sec Or An Applicable Exemption From The Registration Requirements. The Sale Of The Securities In The Private Placements Will Not Involve A Public Offering And Will Be Made Without General Solicitation Or General Advertising. The Investors Represented That They Are Accredited Investors, As Such Term Is Defined In Rule 501(a) Of Regulation D Under The Securities Act, And That They Are Acquiring The Securities For Investment Purposes Only And Not With A View To Any Resale, Distribution Or Other Disposition Of The Securities In Violation Of The U.s. Federal Securities Laws, Financial Statements And Exhibits

Show full article

This functionality is available for registred users only

• Full name
  Adverum Biotechnologies, Inc.
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***